Abiopharma

News list

Director Segedi Bryan K 🟢 acquired 878 shares of EXELON CORP (EXC) at $49.82 Transaction Date: Mar 31, 2026 | Filing ID: 000004

Full text

News bot April 1, 2026, 7:30 p.m.
🔍 Segedi Bryan K (Director)

Company: EXELON CORP (EXC)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 878
Detailed Transactions and Holdings:
- Acquired 878 shares of Common stock- deferred stock units at $49.82 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,451.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Balance includes 72 additional shares acquired through automatic dividend reinvestment.